News
- UK University Hospitals build the NoRCoRP platform
- Scientists tackle vaccine safety, efficacy and access at global R&D forum
- Federal judge enters consent decree against Washington state juice processor
- FDA Warns Firms to Remove Unauthorized E-liquid Products from Market in First Letters Issued to Manufacturers that Did Not Submit Premarket Applications by Deadline
- Family physicians’ crucial role in mental health
- FDA Grants First Conditional Approval Under Expanded Authority to Control Seizures in Dogs with Idiopathic Epilepsy
- Universal health coverage high on the political agenda during the Regional Director’s visit to Georgia
- CBP, FDA Seize Counterfeit, Unauthorized E-Cigarettes
- EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca
- FDA Releases Artificial Intelligence/Machine Learning Action Plan
- UNICEF, WHO, IFRC and MSF announce the establishment of a global Ebola vaccine stockpile
- WHO urges governments to promote healthy food in public facilities
- FDA Conditionally Approves First Oral Tablet to Treat Lymphoma in Dogs
- Neglected tropical diseases: WHO to formally launch new road map for next decade
- Canadian University initiated COVID-19 Emergency Department Registry
- Research Association conducts clinical trial of Eye Movements Recording Using a Smartphone
- Five million COVID-19 cases reported in WHO's Eastern Mediterranean Region
- FDA Issues Alert Regarding SARS-CoV-2 Viral Mutation to Health Care Providers and Clinical Laboratory Staff
- Large clinical trial will test combination monoclonal antibody therapy for mild/moderate COVID-19
- FDA Statement on Following the Authorized Dosing Schedules for COVID-19 Vaccines
- Extra dose from vials of Comirnaty COVID-19 vaccine
- EMA recommends COVID-19 Vaccine Moderna for authorisation in the EU
- FDA Takes Steps to Provide Clarity on Developing New Drug Products in the Age of Individualized Medicine
- HHS Announces $22 Billion in Funding to Support Expanded Testing, Vaccination Distribution
- US Institute conducts cclinical trial of Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Males
Clinical Research News
Prochains essais cliniques
-
Peking University Third HospitalRecrutementHypertension | Dyslipidémie | Maladie pulmonaire obstructive chronique (MPOC) | Diabète sucré de type 2 (DT2) | Maladie coronarienne (CAD) (par exemple, angine, infarctus du myocarde et cardiopathie athérosclérotique (ASHD))Chine
-
Tarsus UniversityThe Scientific and Technological Research Council of Turkey; Mersin UniversityPas encore de recrutement
-
Sun Yat-sen UniversityRecrutementMélanome | Inhibiteur de point de contrôle immunitaireChine
-
NYU Langone HealthPas encore de recrutement
-
Allied Hospital FaisalabadPas encore de recrutement
-
Guizhou Medical UniversityPas encore de recrutementImmunothérapie | Chimioradiothérapie concomitante | Cancer du poumon (NSCLC)Chine
-
The Fourth Affiliated Hospital of Zhejiang University...Pas encore de recrutementCancer du foie (primaire et métastatique)
-
Eli Lilly and CompanyPas encore de recrutementEn bonne santéSingapour, États-Unis
-
Hospital Authority, Hong KongPas encore de recrutementDiagnostic prénatalHong Kong
-
The Fourth Affiliated Hospital of Zhejiang University...Pas encore de recrutement
-
Revision SkincarePas encore de recrutementChute de cheveux | Amincissement des cheveux
-
Vrije Universiteit BrusselUniversity Ghent; Universitair Ziekenhuis Brussel (UZB); Kom op tegen Kanker-Fonds...Pas encore de recrutementLife After CancerBelgique
